As describe in this new article of we see that many new trends will change our vision of the “Pharma” field. We notice that HCS Pharma are involved in almost four points : Use of augmented reality, development of precision medicine, 3D printing (not for drugs but in the drugs discovery process) and use of artificial intelligence to validate test results. It’s not bad for a young startup !

I believe that there is a consensus in the medical community that current regulations concerning drug production; moreover digital health devices or health apps are obsolete. Regulatory agencies are basically unprepared for the waves of digital innovation.

Source: The Top 10 Trends Shaping the Future of Pharma – The Medical Futurist

After having been eclipsed by Target-Based Screening, Phenotypic Screening is finally shining again

The Right Combination

“We take the idea of using drug combinations to treat a disease and apply it to the phenotypic screen. In our particular case, we have successfully employed this approach to multidrug-resistant bacteria and the Ebola virus,” expounds Wei Zheng, Ph.D., a group leader at the National Center for Advancing Translational Sciences, part of the National Institutes of Health (NIH).

Thinking Inside the Black Box

“Remember the ‘Rule of 3’ for phenotypic screens,” urges Dr. Hett. This rule refers to the right cells, the right stimulus, and the right readout. The better the disease is understood, Dr. Hett adds, the better the model system that can be constructed.

Source :

Biotechnologies are growing in Brittany ! C.RIS Pharma, specialized in in vitro and in vivo preclinical development of new active molecules, just move to their new building on “Atalante Saint-Malo” area. More than 1 000 m² are added to the entreprise with 75% of laboratories. We wish them a successful installation!

News from this link:

%d bloggers like this: